Summary
CIENA CORP (CIEN) filed an 8-K on June 3, 2005, reporting a material amendment to its stockholder rights agreement. Specifically, Amendment No. 4, entered into on June 2, 2005, modifies the definition of an "Acquiring Person." This amendment provides an exemption for FMR Corp. (a significant institutional stockholder) and its affiliates from being classified as an "Acquiring Person," provided certain conditions are met. The key condition for FMR Corp. is that its beneficial ownership of Ciena's common stock must remain below 20%. Additionally, FMR Corp. must report its ownership on either a Schedule 13G or 13D, and if a Schedule 13D is filed, it must not express an intention to influence or change Ciena's control, nor participate in any transaction with such a purpose. This filing is significant as it directly addresses the relationship with a major shareholder and potentially alters the company's poison pill defense strategy in relation to FMR Corp.
Key Highlights
- 1Ciena Corporation amended its Stockholder Rights Agreement (poison pill) on June 2, 2005.
- 2The amendment, designated as Amendment No. 4, modifies the definition of an 'Acquiring Person'.
- 3FMR Corp. and its affiliates are exempted from being classified as an 'Acquiring Person' under specific conditions.
- 4The exemption for FMR Corp. is contingent on its beneficial ownership of Ciena's common stock staying below 20%.
- 5A further condition requires FMR Corp. to report its ownership on Schedule 13G or 13D.
- 6If FMR Corp. files a Schedule 13D, it must not indicate an intent to change or influence control of Ciena.
- 7This amendment appears to address potential concerns or arrangements with a significant institutional stockholder, FMR Corp.